Michael Roden

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu et al. · Hepatology · 2023 · 2.9K citations · Full text

Medicine, Internal Medicine, Pathology +17

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Benjamin F. Voight, Laura J. Scott, Valgerður Steinthórsdóttir et al. · Nature Genetics · 2010 · 1.8K citations · Full text

Medicine, Bioinformatics, Endocrinology +16

Systematic identification of trans eQTLs as putative drivers of known disease associations

Harm-Jan Westra, Marjolein J. Peters, Tōnu Esko et al. · Nature Genetics · 2013 · 1.8K citations · Full text

Life Sciences, Genetics, Molecular Genetics +6

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong et al. · Journal of Hepatology · 2024 · 1.6K citations · Full text

Medicine, Internal Medicine, Hepatology +9

Mechanism of free fatty acid-induced insulin resistance in humans.

Michael Roden, Thomas B. Price, Gianluca Perseghin et al. · Journal of Clinical Investigation · 1996 · 1.5K citations · Full text

Life Sciences, Endocrinology, Physiology +17